Intensity Therapeutics, Inc. INTS
We take great care to ensure that the data presented and summarized in this overview for INTENSITY THERAPEUTICS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in INTS
Top Purchases
Top Sells
About INTS
Insider Transactions at INTS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Joseph Talamo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,179
+50.0%
|
$0
$0.26 P/Share
|
|
Jun 30
2025
|
John M Wesolowski Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,745
+47.71%
|
$0
$0.26 P/Share
|
|
Jun 05
2024
|
John M Wesolowski Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+13.0%
|
$4,000
$4.0 P/Share
|
Last 12 Months Summary
Buy / Acquisition
83.9K
Shares
From
2
Insiders
| Grant, award, or other acquisition | 83.9K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders